G protein-mediated signal transduction as a target of antidepressant and antibipolar drug action: Evidence from model systems

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 13, 1996, Pages 49-55

  Rasenick, Mark M ^a   Chaney, Kimberly A ^a   Chen, Jiang ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LITHIUM; VALPROIC ACID;

CONFERENCE PAPER; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG MECHANISM; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TARGETING; HUMAN; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANTIDEPRESSIVE AGENTS; DESIPRAMINE; DOWN-REGULATION; GTP-BINDING PROTEINS; HUMANS; LITHIUM; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, NEUROTRANSMITTER; SIGNAL TRANSDUCTION; VALPROIC ACID;

EID: 0030454869     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Rasenick MM. G's (a poem). Trends Biochem Sci 1992;17:71
2. Rasenick MM, Caron MG, Dolphin AC, et al. Receptor-G protein-effector coupling: coding and regulation of the signal transduction process. In: Cuello AC, Collier B, eds. Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s. Basel, Switzerland: Birkhauser; 1995:91-103
3. Simon M, Strathman M, Gautam N. Diversity of G proteins in signal transduction. Science 1991;252:802-808
4. Kleuss C, Heschler J, Ewel C, et al. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 1991;353:43-48
5. Kleuss C, Scherubl H, Hescheler J. et al. Different β-subunits determine G-protein interaction with transmembrane receptors. Nature 1992;358: 424-426
6. Kleuss C, Scherubl H, Hescheler J. et al. Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins. Science 1993; 259:832-834
7. Popova JS, Johnson GL, Rasenick MM. Chimeric Gαs/Gαi2 proteins define domains on Gαs which interact with tubulin for the β adrenergic activation of adenylyl cyclase. J Biol Chem 1994;269:21748-21754
8. Roychowdhury S, Rasenick MM, Tubulin-G protein association stabilizes GTP binding and activates GTPase: cytoskeletal participation in neuronal signal transduction. Biochemistry 1994;33:9800-9805
9. Wang N, Yan K, Rasenick MM. Tubulin binds specifically to the signal-transducing proteins, Gsα and Giαl. J Biol Chem 1990;265:1239-1242
10. Coppen A. The biochemistry of affective disorders. Br J Psychiatry 1967; 113:1237-1264
11. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965;122:509-522
12. Banerjee SP, Kung LS, Riggi SJ, et al. Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 1977;268:455-456
13. Druker BJ, Mamon HJ, Roberts TM. Oncogenes, growth factors, and signal transduction. N Engl J Med 1989;321:1383-1391
14. Okada F, Tokumitsu Y, Ui M. Desensitization of β-adrenergic receptor-coupled adenylate cyclase in cerebral cortex after in vivo treatment of rats with desipramine. J Neurochem 1986;47:454-459
15. Sulser F. Antidepressant treatments and regulation of norepinephrine-receptor-coupled adenylate cyclase systems in brain. Adv Biochem Psychopharmacol 1984;39:249-261
16. Young LT, Li PP, Kish SJ, et al. Cerebral cortex Gsa protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem 1993;61:890-898
17. Young LT, Li PP, Kish SJ, et al. Postmortem cerebral cortex Gs α-subunit levels are elevated in bipolar affective disorder. Brain Res. 1991;553:323-326
18. Young LT, Li PP, Kish SJ, et al. Cerebral cortex β-adrenoceplor binding in bipolar affective disorder J Affect Disord 1994;30:89-92
19. Baraban JM, Worley PF, Snyder SH. Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium. Psychiatry 1989;146:1251-1259
20. Belmaker RH, Bersudsky Y, Benjamin J, et al. Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry. In: Gessa G, Fratta W, Pani L, et al, eds. Depression and Mania: From Neurobiology to Treatment. New York, NY: Raven Press; 1995:67-84
21. Jope RS, Williams MB. Lithium and brain signal transduction systems. Biochem Pharmacol 1994;47:429-441
22. Manji HK, Potter WZ, Lenox RH. Signal transduction pathways: molecular targets for lithium's actions. Arch Gen Psychiatry 1995;52:531-543
23. Avissar S, Schreiber G, Danon A, et al. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 1988;331: 440-442
24. Avissar S, Schreiber G. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders. Biol Psychiatry 1992;31:435-459
25. Vetulani J, Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic fore-brain. Nature 1975;257:495-497
26. Fishman PH, Finberg JPM. Effect of the tricyclic antidepressant, desipramine on β-adrenergic receptors in cultured rat C6 glioma cells. J Neurochem 1987;49:282-289
27. Hertz L, Richardson J. Acute and chronic effects of antidepressant drugs on β-adrenergic function in astrocytes in primary cultures: an indication of glial involvement in affective disorders? J Neurosci Res 1983;9:173-182
28. Honegger UE, Disler B, Wiesmann UN. Chronic exposure of human cells in culture to the tricyclic antidepressant desipramine reduces the number of β-adrenoceptors. Biochem Pharmacol 1986;35:1899-1902
29. Manier DH, Bieck PR, Duhl DM, et al. The β-adrenoceplor-coupled adenylate cyclase system in rat C6 glioma cells. Neuropsychopharmacology 1992;7:105-112
30. Manji HK, Chen G, Bitran JA, et al. Idazoxan down-regulates β-adreno-receptors on C6 glioma cells in vitro. Eur J Pharmacol 1992;227:275-282
31. Menkes DB, Rasenick MM, Wheeler MA. et al. Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant. Science 1983;219:65-67
32. Ozawa H, Rasenick MM. Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol 1989;36:803-808
33. Ozawa H, Rasenick MM. Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem 1991;30:330-338
34. Chen J, Rasenick MM. Chronic antidepressant treatment facilitates G protein activation without altering G protein content. J Pharmacol Exp Ther 1995;275:509-517
35. Rasenick MM, Talluri M, Dunn WJ III. Photoaffinity guanosine 5′triphosphate analogs as a tool for the study of GTP-binding proteins. Methods Enzymol 1994;237:100-110
36. Chen J, Rasenick MM. Chronic treatment of C6 glioma cells with antidepressant increases functional coupling between a G protein (Gs) and adenylyl cyclase. J Neurochem 1995;64:724-732
37. Popova JS, Rasenick MM. Tubulin activates the G protein Gαq in a manner similar to that seen for Gαs and Gαi. Society for Neuroscience Abstracts 1994;20:190.4
38. Yan K, Greene E, Belga F, et al. Synaptic membrane G proteins are complexed with tubulin in situ. J Neurochem 1996;66:1489-1495